FdaApplication
NDA 021183
Identifiers
- fda_app_no: NDA021183
Properties
| Property | Value |
|---|---|
| applicant_name | BRISTOL MYERS SQUIBB CO |
| application_type | NDA |
| approval_date | 2000-10-31 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| VIDEX EC | DIDANOSINE | 125MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE, DELAYED REL PELLETS;ORAL |
| VIDEX EC | DIDANOSINE | 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE, DELAYED REL PELLETS;ORAL |
| VIDEX EC | DIDANOSINE | 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE, DELAYED REL PELLETS;ORAL |
| VIDEX EC | DIDANOSINE | 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE, DELAYED REL PELLETS;ORAL |
4 products